CNO Financial Group, Inc. 5.125
CNO Financial Group, Inc. 5.125 (CNO-PA) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for CNO Financial Group, Inc. 5.125 (CNO-PA), featuring income statements, balance sheets, and cash flow data.
CNO Financial Group, Inc. 5.125 (CNO-PA) Income Statement & Financial Overview
Explore comprehensive income reports for CNO Financial Group, Inc. 5.125 CNO-PA, broken down by year and quarter.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.004B | $1.11B | $1.12B | $1.07B |
Cost of Revenue | $62.00M | $62.00M | $269.20M | $251.40M |
Gross Profit | $1.004B | $1.10B | $860.40M | $1.07B |
Gross Profit Ratio | $1.00 | $0.99 | $0.77 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | -$79.70M | -$272.50M | -$79.00M | -$214.80M |
Total Costs & Expenses | -$17.70M | $685.90M | -$11.00M | -$150.60M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $62.00M | $62.00M | $68.00M | $64.20M |
Depreciation & Amortization | $77.80M | $76.10M | $74.40M | $71.50M |
EBITDA | $95.50M | $286.60M | $85.40M | $286.30M |
EBITDA Ratio | $0.10 | $0.26 | $0.08 | $0.27 |
Operating Income | $1.004B | $272.50M | $79.00M | $150.60M |
Operating Income Ratio | $1.00 | $0.25 | $0.07 | $0.14 |
Other Income/Expenses (Net) | $0.00 | -$62.00M | $11.00M | -$64.20M |
Income Before Tax | $17.70M | $210.50M | $11.00M | $150.60M |
Income Before Tax Ratio | $0.02 | $0.19 | $0.010 | $0.14 |
Income Tax Expense | $4.00M | $44.40M | $1.70M | $34.30M |
Net Income | $13.70M | $166.10M | $9.30M | $116.30M |
Net Income Ratio | $0.01 | $0.15 | $0.008 | $0.11 |
EPS | $0.14 | $1.62 | $0.09 | $1.08 |
Diluted EPS | $0.13 | $1.58 | $0.09 | $1.06 |
Weighted Avg Shares Outstanding | $100.74M | $102.78M | $105.10M | $107.73M |
Weighted Avg Shares Outstanding (Diluted) | $103.07M | $106.14M | $105.10M | $109.26M |
Over the last four quarters, CNO Financial Group, Inc. 5.125 achieved steady financial progress, growing revenue from $1.07B in Q2 2024 to $1.004B in Q1 2025. Gross profit stayed firm with margins at 100% in Q1 2025 versus 100% in Q2 2024. Operating income totaled $1.004B in Q1 2025, maintaining a 100% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $95.50M. Net income dropped to $13.70M, with EPS at $0.14. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan